4.58 USD
↗ 0.01 (0.33%)AT CLOSE (11:59 AM EDT)
EyePoint, Inc. Common Stock
EYPTNASDAQ • USD
4.58
↘ 0.01 (0.11%)
POST MARKET (AS OF 07:47 PM EDT)
Post Market
AS OF 07:47 PM EDT
4.58
↘ 0.01 (0.11%)
Market: CLOSED
EyePoint, Inc. Common Stock (EYPT) is currently trading at $4.58. Technical and fundamental signals converge bearish — technicals rate "Strong Sell" while fundamentals read "Sell". Key drivers include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 1/9, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. EYPT is fairly valued relative to its sector peers based on current multiples.
Technical & fundamental data as of Sep 4, 2026.
Open?$4.53
High?$4.69
Low?$4.49
Prev. Close?$4.57
Volume?1.9M
Avg. Volume?5.3M
VWAP?$4.60
Rel. Volume?0.36x
Bid / Ask
Bid?$4.56 × 200
Ask?$4.60 × 300
Spread?$0.04
Midpoint?$4.58
Valuation & Ratios
Market Cap?394.9M
Shares Out?86.2M
Float?83.4M
Float %?96.7%
P/E Ratio?N/A
P/B Ratio?2.37
EPS?-$3.56
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
EyePoint Inc focuses is a clinical-stage biopharmaceutical company committed to developing and commercializing therapeutics to improve the lives of patients with serious retinal diseases, that may reduce the frequency of follow-up care. The company's pipeline program includes i) DURAVYU: a sustained-release product candidate for retinal diseases, with the potential to provide patients with improved visual outcomes with less burden. ii) EYP-2301: early-stage program using Durasert E technology to deliver razuprotafib, a TIE-2 agonist targeting VE-PTP for vascular stability in retinal diseases like wet AMD.
Employees
214
Market Cap
394.9M
Industry
LABORATORY ANALYTICAL INSTRUMENTS
Website
Listed
2005-01-27
Address
480 PLEASANT STREET
WATERTOWN, MA 02472
Phone: 617-926-5000
WATERTOWN, MA 02472
Phone: 617-926-5000
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-3/3)
Medium-Term (Wave)?▼ Bearish(-2/3)
Short-Term (Ripple)?– Neutral(0/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?6
Z-Score?0
Momentum?10
Short Sent.?45
Piotroski F-Score?1/9Weak
Altman Z-Score?-7.84Distress
Confidence?64%Moderate
Short InterestSqueeze Risk
Short % of Float?22.10%Squeeze Risk
Short Interest?18.4M
Days to Cover?9.1
Free Float83.4M
Avg Daily Volume2.0M
Settlement Date2026-08-14
Financial Health
Current Ratio?4.50Strong
Quick Ratio?4.46Strong
Cash Ratio?2.63Strong
Debt/Equity?0.00Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score67/100
P/E?N/A▾
P/B?2.37CHEAP▾
Peers100
S&P67
P/S?141.57HIGH▾
Peers100
S&P3
P/FCF?N/A▾
EV/EBITDA?-0.9CHEAP▾
S&P97
EV/Sales?101.97HIGH▾
Peers100
S&P3
Returns & Efficiency
ROE?-184.4%WEAK▾
S&P3
ROA?-134.5%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-271279000
Enterprise Value?$284.4M
Fundamentals ratios updated end of day